Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Shares Outstanding (2020 - 2025)

Journey Medical's Shares Outstanding history spans 6 years, with the latest figure at $21.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 30.9% year-over-year to $21.1 million, compared with a TTM value of $21.1 million through Dec 2025, up 30.9%, and an annual FY2025 reading of $21.1 million, up 30.9% over the prior year.
  • Shares Outstanding for Q4 2025 was $21.1 million at Journey Medical, up from $20.4 million in the prior quarter.
  • The five-year high for Shares Outstanding was $21.1 million in Q4 2025, with the low at $6.0 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $9.7 million, with a median of $6.0 million recorded in 2021.
  • Year-over-year, Shares Outstanding plummeted 50.55% in 2024 and then skyrocketed 191.2% in 2025.
  • Tracing DERM's Shares Outstanding over 5 years: stood at $11.3 million in 2021, then plummeted by 46.98% to $6.0 million in 2022, then surged by 122.07% to $13.3 million in 2023, then rose by 21.24% to $16.2 million in 2024, then soared by 30.9% to $21.1 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Shares Outstanding are $21.1 million (Q4 2025), $20.4 million (Q3 2025), and $17.5 million (Q2 2025).